Heart Pump Device Market Size & Share, Growth Analysis 2032

Heart Pump Device Market Size - By Type (Implanted, Extracorporeal), Device (Ventricular Assist Devices, Total Artificial Hearts, Intra-Aortic Balloon Pumps, Extracorporeal Membrane Oxygenation), Therapy, End-use & Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp; Industry 360° synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights 

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increase in number of heart failures and cardiovascular diseases

3.2.1.2&nbsp;&nbsp;&nbsp;Technological advancements

3.2.1.3&nbsp;&nbsp;&nbsp;Rise in awareness regarding heart failure treatment

3.2.1.4&nbsp;&nbsp;&nbsp;Growing R&amp;D expenditure

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory scenario

3.2.2.2&nbsp;&nbsp;&nbsp;High cost of device and procedures

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.5&nbsp;&nbsp;&nbsp; PESTEL analysis

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.8&nbsp;&nbsp;&nbsp; Regulatory landscape

3.9&nbsp;&nbsp;&nbsp; Technological landscape

3.10&nbsp;&nbsp;&nbsp;GAP analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Implanted heart pump devices

5.3&nbsp;&nbsp;&nbsp; Extracorporeal heart pump devices

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Device, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Ventricular assist devices (VADs)

6.2.1&nbsp;&nbsp;&nbsp; Left ventricular assist devices (LVAD)

6.2.2&nbsp;&nbsp;&nbsp; Right ventricular assist devices (RVAD)

6.2.3&nbsp;&nbsp;&nbsp; Bi-ventricular assist devices (BiVAD)

6.2.4&nbsp;&nbsp;&nbsp; Percutaneous ventricular assist devices (PVAD)

6.3&nbsp;&nbsp;&nbsp; Total artificial hearts (TAHs)

6.4&nbsp;&nbsp;&nbsp; Intra-aortic balloon pumps (IABPs)

6.5&nbsp;&nbsp;&nbsp; Extracorporeal membrane oxygenation (ECMO)

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Therapy, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Destination therapy

7.3&nbsp;&nbsp;&nbsp; Bridge-to-candidacy (BTC) therapy

7.4&nbsp;&nbsp;&nbsp; Bridge-to-transplant (BTT) therapy

7.5&nbsp;&nbsp;&nbsp; Bridge-to-recovery (BTR) therapy

7.6&nbsp;&nbsp;&nbsp; Other therapies

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-use, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Hospitals

8.3&nbsp;&nbsp;&nbsp; Cardiac centers

8.4&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

8.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Italy

9.3.5&nbsp;&nbsp;&nbsp; Spain

9.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.2&nbsp;&nbsp;&nbsp; South Africa

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles 

10.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

10.2&nbsp;&nbsp;&nbsp; ABIOMED

10.3&nbsp;&nbsp;&nbsp; Berlin Heart

10.4&nbsp;&nbsp;&nbsp; BiVACOR Inc.

10.5&nbsp;&nbsp;&nbsp; CARMAT

10.6&nbsp;&nbsp;&nbsp; CorWave SA

10.7&nbsp;&nbsp;&nbsp; Evaheart, Inc.

10.8&nbsp;&nbsp;&nbsp; Fresenius SE &amp; Co. KGaA

10.9&nbsp;&nbsp;&nbsp; Getinge AB

10.10&nbsp;&nbsp;&nbsp; Jarvik Heart

10.11&nbsp;&nbsp;&nbsp; Leviticus Cardio

10.12&nbsp;&nbsp;&nbsp; LivaNova PLC

10.13&nbsp;&nbsp;&nbsp; Medtronic plc

10.14&nbsp;&nbsp;&nbsp; SynCardia Systems, LLC

10.15&nbsp;&nbsp;&nbsp; Teleflex Incorporated 
&nbsp;

Heart Pump Device Market

Get a free sample of this report